10th Annual Forum for Qualified Persons in Pharmacovigilance

This is the only forum designed for QPPVs by QPPVs, now in its 10th year and ever growing. This year’s objectives build on past successes and have been shaped by valuable feedback provided by participants of the past nine meetings. There is an enhanced opportunity for networking as the lectures are followed by a dinner.

Back to Agenda

Session 4 Risk Management and Risk Minimisation Measures: Current Practices, Challenges and Opportunities

Session Chair(s)

Barbara De Bernardi, MD

EUQPPV Vice President - Head of Global QPPV Office

Pfizer S.r.l., Italy

Winrich Rauschning, DrMed, MD, MBA

QPPV

Biolitec Pharma, Germany

Speaker(s)

Risk Minimization Measures: Impact on Pharmacovigilance Practices

George N. Pajovich, RPh

Pfizer Inc, United States

VP, Head of Safety Quality and Risk Management

Risk Management Planning in EU: Key Changes in GVP Module V – A Regulatory Update for EU QPPVs

Emil Andrei Cochino, MD, MHS

European Medicines Agency, Netherlands

Scientific Senior Specialist (Risk Management)

Measuring the Effectiveness of Risk Minimisation Measures: Measuring the Unmeasurable?

Anna Van Troostenburg

Gilead Sciences International Ltd., Germany

Head PV Quality Governance, EU QPPV & VP

Have an account?